与患有抑郁症的年轻人治疗结果相关的生物标志物:系统性审查
Anna Zierotin1, Valeria Mondelli1, Zuzanna Zajkowska1
1Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, The Maurice Wohl Clinical Neuroscience Institute, Cutcombe Road, London, SE5 9RX, UK.
Neuroscience applied
|July 14, 2025
概括
皮质醇,免疫因子和大脑活动等生物标志物可以预测患有抑郁症的年轻人的治疗成功. 了解这些标志物可以帮助定制治疗以获得更好的结果.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 免疫学 免疫学 免疫学
背景情况:
- 对年轻人抑郁症治疗反应的生物标志物的理解有限.
- 青少年和年轻人治疗响应率较低,需要改进治疗选择.
研究的目的:
- 研究皮质醇,免疫和神经标志物与患有抑郁症的年轻人的治疗结果之间的关系.
- 确定心理治疗或抗抑郁药治疗疗效的潜在预测生物标志物.
主要方法:
- 在OVID Medline,EMBASE,全球健康和PsycINFO数据库中的系统文献搜索.
- 包括对被诊断患有重大抑郁症 (MDD) 的青少年 (10-24岁) 的同行评审研究.
- 分析了评估皮质醇,免疫 (例如,因特鲁金,TNF-α) 和神经成像标记物的研究.
主要成果:
- 较高的皮质醇应对压力的反应与较大的症状改善相关.
- 关于SSRI对特定免疫标记物 (IL-1β,IL-4,IL-6,TNF-α) 的影响的不一致的发现表明潜在的炎症亚型.
- 情绪调节大脑区域的激活/连接增加和默认模式网络连接减少与更好的结果相关.
结论:
- 神经和免疫标记物可能在抑郁症治疗机制中发挥作用.
- 确定了几种治疗结果的潜在生物标志物,尽管研究异质性很高.
- 未来的研究需要专注于预测性生物标志物分析和复制.
相关概念视频
Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.


